Abstract:Abstract Many studies have demonstrated that genetic susceptibility played an important role in lung cancer etiology. It has been estimated that microRNAs (miRNAs) may regulate the expression of one third of all human genes and are related to carcinogenesis through their function as oncogenes or tumor suppressors. To test the hypothesis that common sequence variants in microRNA pathways may affect individuals’ lung cancer susceptibility, we assessed the association of 75 haplotype tagging and potential functional single nucleotide polymorphisms (SNPs) in 8 miRNA biogenesis pathway genes with lung cancer risk in a case control study of 1135 lung cancer cases and 803 healthy controls among Caucasians. Overall, SNP rs2302905 from RNASEN exhibited the strongest association and remained significant after adjusting for multiple comparisons using q value at 10% level. Individuals carrying the variant allele of rs2302905 showed a 1.40-fold increased risk of lung cancer (95% CI = 1.11- 1.77; P = 0.0042). Interestingly, similar to rs2302905, two additional SNPs (rs10805564 and rs639174) from RNASEN also showed increased risk of lung cancer (OR = 1.29, 95% CI = 1.04- 1.60; and OR = 1.24, 95% CI = 1.00- 1.53). Two SNPs (rs197412 and rs85276) from DDX20 had significantly reduced lung cancer risk (OR = 0.80, 95% CI = 0.65- 1.00; and OR = 0.78, 95% CI = 0.61- 1.00). Stratified analyses by age, gender, and smoking status identified several additional SNPs that were associated with lung cancer risks in sub-populations. We also counted the number of unfavorable genotypes in each individual to assess the cumulative effect of the top 5 SNPs on lung cancer risk and found a significant gene-dosage effect (P for trend = 0.00028). Compared to the individuals with ≤ 3 unfavorable genotypes in the low risk group, carriers of 4 and 5 unfavorable genotypes had increased risk of lung cancer (OR = 1.30, 95% CI = 0.96 to 1.77; and OR = 2.09, 95% CI = 1.47 to 2.98, respectively). In conclusion, genetic variants in miRNA biogenesis pathway genes may affect the risk of lung cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1174. doi:10.1158/1538-7445.AM2011-1174

Genetic Variations in Cancer-Related Significantly Mutated Genes and Lung Cancer Susceptibility.

SNP rs17079281 Decreases Lung Cancer Risk Through Creating an YY1-Binding Site to Suppress DCBLD1 Expression

Relationship Between Polymorphisms of DNA Repair Gene ERCC1 and Susceptibility to Lung Cancer

Variants in multigene polymorphism association analysis of lung cancer in the Chinese Han population

Polymorphisms and Rare Variants Identified by Next-Generation Sequencing Confer Risk for Lung Cancer in Han Chinese Population.

Integrating Expression-Related SNPs into Genome-Wide Gene- and Pathway-Based Analyses Identified Novel Lung Cancer Susceptibility Genes.

Data from A Rigorous and Comprehensive Validation: Common Genetic Variations and Lung Cancer

Interaction Analysis Between Germline Susceptibility Loci and Somatic Alterations in Lung Cancer.

Systematic Analyses of Regulatory Variants in DNase I Hypersensitive Sites Identified Two Novel Lung Cancer Susceptibility Loci

rs66651343 and rs12909095 confer lung cancer risk by regulating CCNDBP1 expression

Influence of Common Genetic Variation on Lung Cancer Risk: Meta-Analysis of 14 900 Cases and 29 485 Controls

Abstract 1174: Genetic Variations in Microrna Biogenesis Pathway Genes As Susceptibility Loci for Lung Cancer Risk

Exploration of Lung Cancer-Related Genetic Factors via Mendelian Randomization Method Based on Genomic and Transcriptomic Summarized Data

Identification of pathogenic germline variants in a large Chinese lung cancer cohort by clinical sequencing

Genetic Variants of PTPN2 Are Associated with Lung Cancer Risk: a Re-Analysis of Eight GWASs in the TRICL-ILCCO Consortium

Genetic Polymorphisms of FCGR2A, ORAI1 and CD40 Are Associated with Risk of Lung Cancer

Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial.

A Large-Scale Exome-Wide Association Study Identifies Novel Germline Mutations in Lung Cancer

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.

Candidate Variants at 6p21.33 and 6p22.1 and Risk of Non-Small Cell Lung Cancer in a Chinese Population.